Fibroblast growth factor 23 and a novel high-sensitivity troponin I: Early markers and alternative ways of damaging the heart in chronic kidney disease

by F U Dzgoeva, M Yu Sopoev, T M Gatagonova, T L Bestaeva, O V Khamitsaeva
Published 2015-06-01

Osteoprotegerin and fibroblast growth factor 23 in the development of cardiovascular events in chronic kidney disease

by F U Dzgoeva, T M Gatagonova, T L Bestaeva, M Iu Sopoev, B G Bazaeva, O V Khamitsaeva
Published 2014-06-01

Role of fibroblast growth factor 23 in the development of cardiovascular diseases in patients with end-stage renal failure on programmed hemodialysis

by F U Dzgoeva, M Yu Sopoev, T L Bestaeva, O V Khamitsaeva, F A Ktsoeva, R O Sageeva
Published 2016-12-01

Diastolic dysfunction in different types of left ventricular hypertrophy in patients with end- stage renal failure: Impact of long-term erythropoietin therapy

by F U Dzgoeva, T M Gatagonova, Z K Kadzaeva, O V Khamitsaeva, Z Kh Kochisova, A T Dzutseva, B G Bazaeva, T L Bestaeva
Published 2013-06-01

Left ventricular hypertrophy in end-stage renal disease and its possible regression as a result of correction of anemia and arterial hypertension

by Fatima Uruzmagovna Dzgoeva, Tamara Magametovna Gatagonova, Zarina Kazbekovna Kadzaeva, Ol'ga Vasil'evna Khamitsaeva, Zalina Khasanovna Kochisova, Argentina Taymurazovna Dzutseva, Bela Georgievna Bazaeva, F U Dzgoeva, T M Gatagonova, Z K Kadzaeva, O V Khamitsaeva, Z Kh Kochisova, A T Dzutseva, B G Bazaeva
Published 2011-06-01